Cronos Group Inc (CRON)

Duolingo & Roblox: Did Investors Get It Right?

The Motley Fool

Cronos Group (CRON) Q1 2024 Earnings Call Transcript

The Motley Fool

Cronos Group Reports 2024 First Quarter Results

GlobeNewswire Inc.

Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered

The Motley Fool

Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday

The Motley Fool

Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders

GlobeNewswire Inc.

Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024

GlobeNewswire Inc.

Why Marijuana Stocks Got Burnt Today

The Motley Fool

NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?

Benzinga

Why Canopy Growth, Cronos, and Aurora Cannabis Stocks Popped on Monday

The Motley Fool

Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session

Benzinga

Why Canadian Marijuana Stocks Popped Today

The Motley Fool

Why Marijuana Stocks Are Hopping Again on Tuesday

The Motley Fool

Cronos Launches Lord Jones® Chocolate Fusions

GlobeNewswire Inc.

Wall Street Breakfast Podcast: China Blocks Intel, AMD Chips In Government Computers

Seeking Alpha

Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Benzinga

Why Tilray, Cronos, and Canopy Growth Stocks All Popped Today

The Motley Fool

Cronos Group Inc. to Speak at the 36th Annual Roth Conference

GlobeNewswire Inc.

Cronos Group (CRON) Q4 2023 Earnings Call Transcript

The Motley Fool

Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹

GlobeNewswire Inc.

Cannabis Stocks: Here's How to Maximize Your Gains Amid Sector's Strong Resurgence

Investing.com

Village Farms International Sustains High Cannabis EBITDA Margins, Setting Stage For Growth, Market Research Shows

Benzinga

Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024

GlobeNewswire Inc.

Is It Too Late to Buy Altria Stock?

The Motley Fool

Curaleaf, Truelive, Verano could benefit from marijuana reclassification

MarketWatch

Cronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1

GlobeNewswire Inc.

Green Thumb, Trulieve and other cannabis stocks up as much as 23% as details emerge on HHS recommendation to lower drug classification

MarketWatch

Green Thumb, Trulieve and other cannabis stocks up as much as 21% as details emerge on HHS recommendation to lower drug classification

MarketWatch

Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Benzinga

FLJ Group, Bit Digital And Other Big Stocks Moving Higher In Friday's Pre-Market Session

Benzinga

B of A Securities Maintains Underperform Rating for Cronos Group: Here's What You Need To Know

Benzinga

Want Decades of Passive Income? 3 Stocks to Buy Now

The Motley Fool

Switching From Tomatoes To Cost-Efficient Cannabis Boosts Company's Stock By 35%

Benzinga

Premium Cannabis Brand Lord Jones® Launches Live Resin Vapes

GlobeNewswire Inc.

How Much Do Canadians Spend On Marijuana? A Look At Third Quarter 2023 Sales Data

Benzinga

Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility

GlobeNewswire Inc.